APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anca Vasculitis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anca Vasculitis Drug Industry Growth and Trends Forecast to 2032

Report ID 173963380119 December 202573 pages

Choose your research edition.

Industry ResearchAnca Vasculitis Drug Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Anca Vasculitis Drug Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Anca Vasculitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anca Vasculitis Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Anca Vasculitis Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anca Vasculitis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anca Vasculitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anca Vasculitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anca Vasculitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anca Vasculitis Drug include ChemoCentryx, Inc., Kineta, Inc. and GlaxoSmithKline plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anca Vasculitis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anca Vasculitis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anca Vasculitis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anca Vasculitis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anca Vasculitis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anca Vasculitis Drug Market by Company

ChemoCentryx, Inc.

Kineta, Inc.

GlaxoSmithKline plc

Anca Vasculitis Drug Segment by Type

Dalazatide

Belimumab

CCX-168

CCX-1378

Others

Anca Vasculitis Drug Segment by Application

Hospital

Clinic

Others

Anca Vasculitis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anca Vasculitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anca Vasculitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anca Vasculitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anca Vasculitis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anca Vasculitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dalazatide Table 2. Major Company of Belimumab Table 3. Major Company of CCX-168 Table 4. Major Company of CCX-1378 Table 5. Major Company of Others Table 6. Global Anca Vasculitis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Anca Vasculitis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anca Vasculitis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anca Vasculitis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Anca Vasculitis Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Anca Vasculitis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anca Vasculitis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anca Vasculitis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Anca Vasculitis Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Anca Vasculitis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Anca Vasculitis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Anca Vasculitis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Anca Vasculitis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Anca Vasculitis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Anca Vasculitis Drug Industry Trends Table 28. Anca Vasculitis Drug Industry Drivers Table 29. Anca Vasculitis Drug Industry Opportunities and Challenges Table 30. Anca Vasculitis Drug Industry Restraints Table 31. Global Anca Vasculitis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anca Vasculitis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Anca Vasculitis Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Anca Vasculitis Drug Sales Share by Company (2021-2026) Table 35. Global Anca Vasculitis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Anca Vasculitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anca Vasculitis Drug Major Company Production Sites and Headquarters Table 38. Global Anca Vasculitis Drug Company, Product Type & Application Table 39. Global Anca Vasculitis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anca Vasculitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anca Vasculitis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anca Vasculitis Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Anca Vasculitis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anca Vasculitis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anca Vasculitis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Anca Vasculitis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Anca Vasculitis Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Anca Vasculitis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anca Vasculitis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anca Vasculitis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Anca Vasculitis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Anca Vasculitis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Anca Vasculitis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anca Vasculitis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anca Vasculitis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Anca Vasculitis Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Anca Vasculitis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anca Vasculitis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anca Vasculitis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Anca Vasculitis Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Anca Vasculitis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Anca Vasculitis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Anca Vasculitis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Anca Vasculitis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Anca Vasculitis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. ChemoCentryx, Inc. Company Information Table 75. ChemoCentryx, Inc. Business Overview Table 76. ChemoCentryx, Inc. Anca Vasculitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. ChemoCentryx, Inc. Anca Vasculitis Drug Product Portfolio Table 78. ChemoCentryx, Inc. Recent Development Table 79. Kineta, Inc. Company Information Table 80. Kineta, Inc. Business Overview Table 81. Kineta, Inc. Anca Vasculitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Kineta, Inc. Anca Vasculitis Drug Product Portfolio Table 83. Kineta, Inc. Recent Development Table 84. GlaxoSmithKline plc Company Information Table 85. GlaxoSmithKline plc Business Overview Table 86. GlaxoSmithKline plc Anca Vasculitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline plc Anca Vasculitis Drug Product Portfolio Table 88. GlaxoSmithKline plc Recent Development Table 89. North America Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 90. North America Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 91. North America Anca Vasculitis Drug Sales Market Share by Country (2021-2026) Table 92. North America Anca Vasculitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 93. North America Anca Vasculitis Drug Sales Market Share Forecast by Country (2027-2032) Table 94. North America Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 95. North America Anca Vasculitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 96. North America Anca Vasculitis Drug Market Share by Country (2021-2026) Table 97. North America Anca Vasculitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 98. North America Anca Vasculitis Drug Market Share Forecast by Country (2027-2032) Table 99. Europe Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. Europe Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 101. Europe Anca Vasculitis Drug Sales Market Share by Country (2021-2026) Table 102. Europe Anca Vasculitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 103. Europe Anca Vasculitis Drug Sales Market Share Forecast by Country (2027-2032) Table 104. Europe Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. Europe Anca Vasculitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 106. Europe Anca Vasculitis Drug Market Share by Country (2021-2026) Table 107. Europe Anca Vasculitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. Europe Anca Vasculitis Drug Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 111. Asia-Pacific Anca Vasculitis Drug Sales Market Share by Country (2021-2026) Table 112. Asia-Pacific Anca Vasculitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 113. Asia-Pacific Anca Vasculitis Drug Sales Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Anca Vasculitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. Asia-Pacific Anca Vasculitis Drug Market Share by Country (2021-2026) Table 117. Asia-Pacific Anca Vasculitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Asia-Pacific Anca Vasculitis Drug Market Share Forecast by Country (2027-2032) Table 119. Latin America Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Latin America Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 121. Latin America Anca Vasculitis Drug Sales Market Share by Country (2021-2026) Table 122. Latin America Anca Vasculitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 123. Latin America Anca Vasculitis Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Latin America Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Latin America Anca Vasculitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Latin America Anca Vasculitis Drug Market Share by Country (2021-2026) Table 127. Latin America Anca Vasculitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Latin America Anca Vasculitis Drug Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 131. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Country (2021-2026) Table 132. Middle East and Africa Anca Vasculitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 133. Middle East and Africa Anca Vasculitis Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Anca Vasculitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Anca Vasculitis Drug Market Share by Country (2021-2026) Table 137. Middle East and Africa Anca Vasculitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Middle East and Africa Anca Vasculitis Drug Market Share Forecast by Country (2027-2032) Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Anca Vasculitis Drug Distributors List Table 142. Anca Vasculitis Drug Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Anca Vasculitis Drug Image Figure 2. Global Anca Vasculitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anca Vasculitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anca Vasculitis Drug Sales (2021-2032) & (K Units) Figure 5. Dalazatide Image Figure 6. Global Dalazatide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Belimumab Image Figure 8. Global Belimumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. CCX-168 Image Figure 10. Global CCX-168 Sales YoY Growth (2021-2032) & (K Units) Figure 11. CCX-1378 Image Figure 12. Global CCX-1378 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Anca Vasculitis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anca Vasculitis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Anca Vasculitis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Anca Vasculitis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Anca Vasculitis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anca Vasculitis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anca Vasculitis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anca Vasculitis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anca Vasculitis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anca Vasculitis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anca Vasculitis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anca Vasculitis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anca Vasculitis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Anca Vasculitis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Anca Vasculitis Drug Market Share by Application 2025 VS 2032 Figure 37. North America Anca Vasculitis Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Anca Vasculitis Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Anca Vasculitis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Anca Vasculitis Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Anca Vasculitis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Anca Vasculitis Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Anca Vasculitis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Anca Vasculitis Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Anca Vasculitis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Anca Vasculitis Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Anca Vasculitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Anca Vasculitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Anca Vasculitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Anca Vasculitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anca Vasculitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Anca Vasculitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anca Vasculitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Anca Vasculitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anca Vasculitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Anca Vasculitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anca Vasculitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Anca Vasculitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anca Vasculitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Anca Vasculitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anca Vasculitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Anca Vasculitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anca Vasculitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Anca Vasculitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anca Vasculitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Anca Vasculitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anca Vasculitis Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Anca Vasculitis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dalazatide
  • Belimumab
  • CCX-168
  • CCX-1378
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • ChemoCentryx, Inc.
  • Kineta, Inc.
  • GlaxoSmithKline plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anca Vasculitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anca Vasculitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anca Vasculitis Drug Market by Type
  6. 1.3.1 Dalazatide
  7. 1.3.2 Belimumab
  8. 1.3.3 CCX-168
  9. 1.3.4 CCX-1378
  10. 1.3.5 Others
  11. 1.4 Global Anca Vasculitis Drug Market Size by Type
  12. 1.4.1 Global Anca Vasculitis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anca Vasculitis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anca Vasculitis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anca Vasculitis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anca Vasculitis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anca Vasculitis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anca Vasculitis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anca Vasculitis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anca Vasculitis Drug Industry Trends
  2. 2.2 Anca Vasculitis Drug Industry Drivers
  3. 2.3 Anca Vasculitis Drug Industry Opportunities and Challenges
  4. 2.4 Anca Vasculitis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anca Vasculitis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Anca Vasculitis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Anca Vasculitis Drug Price (2021-2026)
  4. 3.4 Global Anca Vasculitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anca Vasculitis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Anca Vasculitis Drug Company, Product Type & Application
  7. 3.7 Global Anca Vasculitis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anca Vasculitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anca Vasculitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anca Vasculitis Drug Tier 1, Tier 2, and Tier 3
4 Anca Vasculitis Drug Regional Status and Outlook
  1. 4.1 Global Anca Vasculitis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anca Vasculitis Drug Historic Market Size by Region
  3. 4.2.1 Global Anca Vasculitis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anca Vasculitis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anca Vasculitis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anca Vasculitis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Anca Vasculitis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anca Vasculitis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anca Vasculitis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anca Vasculitis Drug by Application
  1. 5.1 Anca Vasculitis Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Anca Vasculitis Drug Market Size by Application
  6. 5.2.1 Global Anca Vasculitis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anca Vasculitis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anca Vasculitis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anca Vasculitis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anca Vasculitis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anca Vasculitis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anca Vasculitis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anca Vasculitis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ChemoCentryx, Inc.
  2. 6.1.1 ChemoCentryx, Inc. Company Information
  3. 6.1.2 ChemoCentryx, Inc. Business Overview
  4. 6.1.3 ChemoCentryx, Inc. Anca Vasculitis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Product Portfolio
  6. 6.1.5 ChemoCentryx, Inc. Recent Developments
  7. 6.2 Kineta, Inc.
  8. 6.2.1 Kineta, Inc. Company Information
  9. 6.2.2 Kineta, Inc. Business Overview
  10. 6.2.3 Kineta, Inc. Anca Vasculitis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kineta, Inc. Anca Vasculitis Drug Product Portfolio
  12. 6.2.5 Kineta, Inc. Recent Developments
  13. 6.3 GlaxoSmithKline plc
  14. 6.3.1 GlaxoSmithKline plc Company Information
  15. 6.3.2 GlaxoSmithKline plc Business Overview
  16. 6.3.3 GlaxoSmithKline plc Anca Vasculitis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline plc Anca Vasculitis Drug Product Portfolio
  18. 6.3.5 GlaxoSmithKline plc Recent Developments
7 North America by Country
  1. 7.1 North America Anca Vasculitis Drug Sales by Country
  2. 7.1.1 North America Anca Vasculitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anca Vasculitis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Anca Vasculitis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anca Vasculitis Drug Market Size by Country
  6. 7.2.1 North America Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anca Vasculitis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Anca Vasculitis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anca Vasculitis Drug Sales by Country
  2. 8.1.1 Europe Anca Vasculitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anca Vasculitis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Anca Vasculitis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anca Vasculitis Drug Market Size by Country
  6. 8.2.1 Europe Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anca Vasculitis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anca Vasculitis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anca Vasculitis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Anca Vasculitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anca Vasculitis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anca Vasculitis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anca Vasculitis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anca Vasculitis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anca Vasculitis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anca Vasculitis Drug Sales by Country
  2. 10.1.1 South America Anca Vasculitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anca Vasculitis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Anca Vasculitis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anca Vasculitis Drug Market Size by Country
  6. 10.2.1 South America Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anca Vasculitis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Anca Vasculitis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anca Vasculitis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Anca Vasculitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anca Vasculitis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anca Vasculitis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anca Vasculitis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Anca Vasculitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anca Vasculitis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anca Vasculitis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anca Vasculitis Drug Value Chain Analysis
  2. 12.1.1 Anca Vasculitis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anca Vasculitis Drug Production Mode & Process
  7. 12.2 Anca Vasculitis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anca Vasculitis Drug Distributors
  10. 12.2.3 Anca Vasculitis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst